Curanex Pharmaceuticals Inc
CURX · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Xie Liqin: Form 3
Insider disclosure · Filed · Report period 25 Aug 2025
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- CURX · 23126K106 - COM
Company details and SEC sources
CIK 0002025942 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CURX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2 Jericho Plaza,, Suite101 B, Jericho, NY, 11753
- Incorporated in
- NV
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields